跳至主要内容
临床试验/NCT05416385
NCT05416385招募中不适用

Combining Intraplaque Neovascularization with Risk Stratification by Carotid Stress ECHO

Dr. Amer Johri6 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2021年8月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,500
试验地点
6
主要终点
Our primary outcomes will be the improvement in sensitivity and negative predictive value (NPV).

研究概览

简要总结

The root cause of heart attacks and strokes is atherosclerosis, the hardening and thickening of blood vessels due to the presence of "plaque" which is a build-up of fat and cholesterol in the walls of vessels. To diagnose heart disease, patients receive a stress test to find out if they require surgery. Up to 52% of patients receiving an angiogram (surgery) to look at plaque blockages in the heart are found to be normal (no blockage). Patients who are suspected of having heart disease often undergo a stress test, which helps cardiologists decide if the patient has heart disease, but stress tests can give false results. In Ontario alone, 90% are stress tests are found to be normal and patients are sent home with little follow-up. Of these 3-5% (~4,000 patients/year) will have a major cardiovascular event (heart attack, surgery, or death) within 3 years. We need to improve the stress test accuracy to reduce cardiac outcome. We now know that it is not just the total amount of plaque that leads to heart attacks and strokes, but the composition of the plaque that can lead to breakage causing a heart attack. Plaques are soft and fragile, and typically contain fat and small leaky blood vessels within their cores. If we are able to identify patients that have leaky plaques using ultrasound, we may be able to improve the accuracy of stress testing. We propose a study looking at the combination of stress testing (assessing heart function) and neck ultrasound (assessing plaque composition), to identify patients at risk for cardiovascular events (heart attacks and death). We will enrol patients from 6 sites across Canada and follow-them for cardiac outcome for 3 years.

详细描述

Primary Aim: To determine if carotid intraplaque neovascularization score (IPN) combined with stress echo (SE) [IPN+SE] enhances prediction of 3-year major adverse cardiovascular events (MACE) compared to SE alone.

Objectives: 1) The % change in test sensitivity of IPN+SE for predicting 3-year MACE compared with SE alone. 2) The Net Reclassification Improvement (NRI) for MACE will be determined (patients "missed" by the SE, but captured as high risk for MACE by IPN).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women >18 years;
  • Referred for a clinically indicated SE for assessment of ischemia and risk stratification;
  • Able and willing to give informed consent.

排除标准

  • Emergency procedure, or active acute coronary syndrome (active chest pain, ischemic electrocardiogram changes, or cardiac enzyme elevation);
  • Referral for viability, pulmonary hypertension, or valve assessment;
  • Referral outside of the normal working hours;
  • History of significant CAD: percutaneous coronary intervention (PCI), coronary artery bypass graft (GABG), or coronary angioplasty;
  • History of stroke or myocardial infarction (MI);
  • Known or documented hypersensitivity or allergy to perflutren (DEFINITY® contrast agent);
  • Known or documented allergy to Polyethylene Glycol (Peg) a component of DEFINITY®;
  • History of carotid surgery (endarterectomy or stenting);
  • Any serious medical condition or complication from the stress test that according to the investigator could interfere with the carotid scan or optimal care;
  • Currently pregnant or breastfeeding;
  • Previous enrolment into the study.

结局指标

主要结局

Our primary outcomes will be the improvement in sensitivity and negative predictive value (NPV).

时间窗: This is a 5-year study. The outcome follow up for mace will be 3-years from the index date (SE).

Our primary analysis will compare the sensitivity of an established binary test based on SE alone to a binary test based on SE and plaque assessment (using established thresholds, IPN≥1.25) to predict 3-year MACE.

次要结局

未报告次要终点

研究者

发起方
Dr. Amer Johri
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Amer Johri

Professor

Queen's University

研究点 (6)

Loading locations...

相似试验